Phase 3, 1, Gastrointestinal Cancer, Phase 3, 8, Non-small cell lung cancer (NSCLC), Phase 3, 2, Cardiovascular Disease, Phase 3, 12, Renal Cell Carcinoma, Phase 3, 6, Neovascular (wet) Age-related Macular Degeneration, Phase 3, 5, Influenza (Vaccine Trial), Phase 3, 8, Malnourishment, Phase 3, 5, Refractory or Unexplained Chronic Cough, Phase 3, 5, Haemophilic Arthropathy, Phase 3, 1, Hepatitis Delta, Phase 2, 1, Ulcerative Colitis, Phase 3, 8, COVID-19 (Treatment Trial), Phase 2/3, 6, COVID-19 (Treatment Trial), Phase 2/3, 10, COVID-19 (Treatment Trial), Phase 3, 11, COVID-19 (Treatment Trial), Phase 3, 7, COVID-19 (Vaccine Trial), Phase 3b, 9, COVID-19 (Vaccine Trial), Phase 3, 4, COVID-19 (Vaccine Trial), Non-interventional Real-World Study, 2, Advanced non-small cell lung cancer & Advanced liver (hepatocellular) cancer, Non-interventional Retrospective Real-World Study, 5, Type 2 Diabetes Mellitus, Phase 3, Pulmonary Tuberculosis, Phase 3, COVID-19 (Treatment Trial), Phase 2/3, COVID-19 (Treatment Trial), Phase 3, COVID-19 (Vaccine Trial), Phase 3, Anaemia in Pregnancy, Phase 3, Candidiasis including Candidemia, caused by Candida Auris, Phase 3, Fungal Diseases that are Refractory to or Intolerant of Standard Antifungal Treatment, Phase 3, Acute Severe Diarrhea amongst Children in Low resource settings, Phase 3, Perioperative Bleeding, Venous Thrombosis & Arterial Thrombosis, Phase 3, Prevention of Maternal and Neonatal Death/Infections, Phase 3, Pulmonary Tuberculosis